Trichology News

Spironolactone and Other Androgen Blockers Might Protect Against Coronavirus, Study Indicates

Medscape reports that while “concerns about potential risks about the use of spironolactone for acne during the COVID-19 pandemic were raised on social media last month,” researchers found that “spironolactone and other androgen blockers might actually protect against the virus.” The findings were published in the Journal of the American Academy of Dermatology. Medscape adds, “The American Academy of Dermatology has not said to stop spironolactone.”